Professor Anthony Wierzbicki

Professor Anthony Wierzbicki

Chemical pathology 03192221

  • Not Fee assured
  • Open Referral network
Not Fee assured
Open Referral network

Specialises in

  • Metabolic medicine

About me

Professor Anthony Wierzbicki is consultant in metabolic medicine/chemical pathology at Guy’s & St. Thomas’ Hospitals (GSTT) and honorary Professor in Cardiometabolic Disease at King’s College, London. He runs a regional centre for lipid disorders and a national orphan lipid disease clinic and runs lipid pheresis services within GSTT. He is clinical lead forClinical Biochemistry at Synlab at Guy’s & St Thomas’ Hospitals. He is secretary of the national network of specialist Lipid laboratories and Genomic Medicine Services Alliance lead for Familial Hypercholesterolaemia (FH) in SE England.
His research interests are in the role of lipids in atherosclerosis and in peroxisomal diseases. He is a Fellow of the American Heart Association and the National Academy of Clinical Biochemistry (USA). He has published 400 papers, 19 book chapters including for the Oxford Textbook of Medicine and Kumar & Clark’s Pathology and 1 book. He was a trustee of HEART-UK (UK Cholesterol charity) and chairman of its medical and scientific committee (2002-08). He is a committee member of FH-Europe and the DARE Foundation for Refsum disease.
He helped write the International guidelines on FH (2014) and the American Heart Association scientific consensus statement on FH (2015). At the National Institute for Health and Clinical Excellence (NICE) he has served on the Technology Appraisal (2006-09), Highly Specialised (orphan disease) Therapies (2013-15) and Diagnostics Appraisal committees (2014-20). He was a member of the FH guideline group (CG71; 2008-09) and chaired the Lipid Modification and Cardiovascular Risk (CG181; 2012-14); Chronic Heart Failure (NG106; 2016-18), Hypertension (NG136; 2017-19) and now Chronic Kidney Disease guidelines (CG182; 2018-21).

Areas of interest

Hyperlipidaemia; cholesterol; triglycerides; cardiovascular risk assessment; rare lipid disorders

Medical secretaries

About me
My outcomes
My qualifications & training
My private practice
Consultant's practices
Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.